Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP934693.RAsHsBYc1VIfCW1s09DHgtWHDyDD_hMHatwhnqQK6BKBU130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934693.RAsHsBYc1VIfCW1s09DHgtWHDyDD_hMHatwhnqQK6BKBU130_provenance.
• NP451091.RAqVxDXFSMFw0fFhUVqy7TYpmsutXckuV0Jl7ICLIKeFk130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451091.RAqVxDXFSMFw0fFhUVqy7TYpmsutXckuV0Jl7ICLIKeFk130_provenance.
• NP914625.RAji-iOG1h9HYFd-d3XzEYiETCaGZtcuTTc_z6XiK4Zag130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914625.RAji-iOG1h9HYFd-d3XzEYiETCaGZtcuTTc_z6XiK4Zag130_provenance.
• NP189199.RAyRB4zGA3aHPDWjmeGecahVN4XULCTYQwkQSn8ORUB0g130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189199.RAyRB4zGA3aHPDWjmeGecahVN4XULCTYQwkQSn8ORUB0g130_provenance.
• NP285917.RAO6CPL7_oLINWaL5i_LgOchzqneSe8XVojM6EIPx5Fk0130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285917.RAO6CPL7_oLINWaL5i_LgOchzqneSe8XVojM6EIPx5Fk0130_provenance.
• NP731672.RA4Dtai_WEivXSnYeQzjiIDCsNbpdiRjZCJwFx4I5rf6o130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731672.RA4Dtai_WEivXSnYeQzjiIDCsNbpdiRjZCJwFx4I5rf6o130_provenance.
• NP625000.RAe0pF_S6OuvIeEXP9Z3SZtmU-5Roy3k7wN5odJ5rZRUc130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625000.RAe0pF_S6OuvIeEXP9Z3SZtmU-5Roy3k7wN5odJ5rZRUc130_provenance.
• NP621151.RAWFRiL3P5pvddeHIkK33svjxPVvlNtXFXueyXG11bObo130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621151.RAWFRiL3P5pvddeHIkK33svjxPVvlNtXFXueyXG11bObo130_provenance.
• assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP653727.RApKVI44v7VAyWbsJVJGUEJMmG7OvNj5aWjC4fey1umao130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653727.RApKVI44v7VAyWbsJVJGUEJMmG7OvNj5aWjC4fey1umao130_provenance.
• NP623862.RANSIsaRT81V1i07tEj9os8RgVwcjwjtZn-I_CrN77CsI130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623862.RANSIsaRT81V1i07tEj9os8RgVwcjwjtZn-I_CrN77CsI130_provenance.
• NP622548.RA6sakNm3WsCA57s-_v4co3LBfIWDbh8EU52flbtRe4Jg130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622548.RA6sakNm3WsCA57s-_v4co3LBfIWDbh8EU52flbtRe4Jg130_provenance.
• NP653723.RAGXclVApKOhlLGFPO8wh0ieOyp60UZlM9MSTIq2np7fI130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653723.RAGXclVApKOhlLGFPO8wh0ieOyp60UZlM9MSTIq2np7fI130_provenance.
• NP653724.RA3JzP3KSoe6EuAIGRjcTeOKmsh_mT2G6yPCNht5ce_6o130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653724.RA3JzP3KSoe6EuAIGRjcTeOKmsh_mT2G6yPCNht5ce_6o130_provenance.
• NP653725.RA9PWfTjVrCf1pxkN1YfqPNT4IXRv3ikygk0fji2rbmzk130_assertion description "[The frequent loss of expression of the tumour suppressor gene PTEN suggests involvement of the PI3K-AKT/protein kinase B (PKB) pathway in MPMs, which may be relevant for future mesothelioma treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653725.RA9PWfTjVrCf1pxkN1YfqPNT4IXRv3ikygk0fji2rbmzk130_provenance.